Roswell Park Cancer Institute, State University of NY
Dr. Roswell Park, a physician and professor of surgery at the University of Buffalo School of Medicine, founded the Roswell Park Cancer Institute in 1898. The establishment of Roswell Park Cancer Institute as an institute of treatment and cancer research was the first of its kind in the world. In 1904, the Institute initiated the first chemotherapy program world history.
Roswell Park Cancer Institute has been awarded status as a National Cancer Institute comprehensive center since 1974. To date, the hospital employs over 3,000 physicians, residents, nurses, and fellows and admits an estimated 4,500 patients for inpatient care and 168,000 for outpatient treatment.
The Roswell Park Cancer Institute carries a long tradition of cancer care and research excellence. As one of the nation’s leading cancer research and treatment centers, the Roswell Park Cancer Institute receives an estimated $36 million dollars each year to conduct oncological research from the National Cancer Institute. Their facility totals over 1.6 million square feet to combine the traditional cancer hospital with laboratory and research facilities.
The Roswell Park Cancer Institute’s commitment to cutting edge research and patient-centered therapies continues to support its ranking and accolades in the US News and World Report as one of the “Best Cancer Hospitals” in the US. Additionally, notable staff have won the Nobel Prize in Physiology, NIH and NCI grants, pioneered photodynamic therapy, contributed to the Human Genome Project, and have lead to numerous cancer detection and treatment discoveries.
The Roswell Park Cancer Institute is situated to provide the latest research developments to provide improved cancer treatment options. The integrated research environment provides collaboration of laboratory scientists and physicians within clinical, translational, and prevention research studies.
With regard to mesothelioma, the Roswell Park Cancer Institute offers several specific, innovative treatments that are being researched in addition to the comprehensive cancer treatments listed below. These include clinical trials, minimally invasive surgery, targeted radiation therapy and radiofrequency ablation, photodynamic therapy, and combinational treatment approaches to cure cancer.
Radiation oncology, surgical oncology, clinical trials, chemotherapy, palliative care, state of the art diagnostics and imaging services, pathology, genetic counseling, hormone therapy, biological therapy, complementary and alternative medicine, nutrition and physical therapy, and comprehensive and preventive care are all options in the NYU Cancer Institute’s cancer treatment program.
Currently, the Roswell Park Cancer Institute, along with thoracic surgeons John Kane III, MD, FACS, and Sai Yendamuri, MD, FACS, offers distinguished specialists in mesothelioma treatment. They operate and/or direct many innovative treatments, such as photodynamic therapy, as well as piloting clinical trials.
Experienced professionals and health care providers. Find through our database of Mesothelioma Doctors & Hospitals.